Dux Ducis Pharmaceuticals Private Limited
About Dux Ducis Pharmaceuticals Private Limited
Data last updated:
Dux Ducis Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51101MH2014PTC254173. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anuradha Shridhar Giri and Vaibhav Mahadeorao Giri.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Shop No. 3 Beach View Apt Palm Beach Road Sector 6 Nerul, Navi Mumbai, Maharashtra, India – 400706.
As per the financials filed for FY 2019, the company reported a revenue of ₹4.46 Lakh, a decline of 56% compared to the previous year. For the same year it recorded a net loss of ₹3.56 Lakh (net margin -79.7%) and EBITDA of -₹3.56 Lakh (EBITDA margin -79.7%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years.
As per MCA filings, the company has open charges of ₹18.75 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No. 3 Beach View Apt Palm Beach Road Sector 6 Nerul, Navi Mumbai, Maharashtra, India – 400706
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dux Ducis Pharmaceuticals Private Limited
The main business activity of Dux Ducis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dux Ducis Pharmaceuticals Private Limited FY 2019 filings available
Dux Ducis Pharmaceuticals Private Limited reported revenue of ₹4.46 Lakh (down 56% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR) of Dux Ducis Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 45% over three years, including a 56% fall in the latest year. EBITDA fell 658% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dux Ducis Pharmaceuticals Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹4.46 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.56 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.56 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dux Ducis Pharmaceuticals Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -79.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -79.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dux Ducis Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dux Ducis Pharmaceuticals Private Limited
Dux Ducis Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ecm Engineers (India) Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| Dr Herbmed Private Limited | •••• | •••• | •••• | •••• | - | Rajkot, Gujarat, India |
| N.N. Drugs Private Limited | •••• | •••• | •••• | •••• | - | Patna., Bihar, India |
| Jas-Jai Tradecon Private Limited | •••• | •••• | •••• | •••• | - | Aurangabad, Maharashtra, India |
| D R T Pipes Private Limited | •••• | •••• | •••• | •••• | - | Chandigarh, India |
| Dux Ducis Pharmaceuticals Private Limited this company | •••• | •••• | •••• | •••• | - | Navi Mumbai, Maharashtra, India |
| Om Shrinath Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Nagpur, Maharashtra, India |
| Hecta Nutrition Private Limited | •••• | •••• | •••• | •••• | - | Delhi, India |
| Mechacitek Engineering Consultant Private Limited | •••• | •••• | •••• | •••• | - | Ranchi, Jharkhand, India |
| Devine Ocular Devices Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| VJH Lifecare Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Dux Ducis Pharmaceuticals by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Dux Ducis Pharmaceuticals Private Limited
Dux Ducis Pharmaceuticals Private Limited is audited by KOCHAR DESAI & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KOCHAR DESAI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dux Ducis Pharmaceuticals Private Limited
Dux Ducis Pharmaceuticals has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuradha Shridhar Giri | Director | 10 Dec 2014 | 11 Years 9 Months | Current |
| Vaibhav Himatrao Pande | Additional Director | 15 Dec 2018 | 7 Years 9 Months | Current |
| Yogesh Subhash Kanchalwar | Additional Director | 15 Dec 2018 | 7 Years 9 Months | Current |
| Vaibhav Mahadeorao Giri | Director | 12 Mar 2014 | 12 Years 6 Months | Current |
| Vivekanand Sudhakar Manwatkar | Additional Director | 18 Sep 2017 | 9 Years 0 Months | Current |
| Prashant Rupchand Pakhidde Also directs: Skyhigh Knowledge Solution Private Limited | Additional Director | 18 Sep 2017 | 9 Years 0 Months | Current |
Ownership and Shareholding of Dux Ducis Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dux Ducis Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2015 | Punjab National Bank | ₹18.75 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Dux Ducis Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Dux Ducis Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dux Ducis Pharmaceuticals Private Limited
Dux Ducis Pharmaceuticals Private Limited has 7 board changes on record since 2014: 6 appointments and 1 cessation. The latest: Vaibhav Himatrao Pande was appointed as Additional Director on 15 Dec 2018.
Credit Ratings, Litigation & Regulatory Alerts for Dux Ducis Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dux Ducis Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dux Ducis Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dux Ducis Pharmaceuticals Private Limited
Dux Ducis Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dux Ducis Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dux Ducis Pharmaceuticals Private Limited
Dux Ducis Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 March 2014 (12+ years old) and is registered under CIN U51101MH2014PTC254173.
Dux Ducis Pharmaceuticals reported revenue of ₹4.46 Lakh for FY 2019 (down 56% YoY).
Dux Ducis Pharmaceuticals has 6 current directors:
- Anuradha Shridhar Giri - Director
- Vaibhav Himatrao Pande - Additional Director
- Yogesh Subhash Kanchalwar - Additional Director
- Vaibhav Mahadeorao Giri - Director
- Vivekanand Sudhakar Manwatkar - Additional Director
- Prashant Rupchand Pakhidde - Additional Director
Dux Ducis Pharmaceuticals reported a net loss of ₹3.56 Lakh (net margin -79.7%) and EBITDA of -₹3.56 Lakh (EBITDA margin -79.7%) for FY 2019, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dux Ducis Pharmaceuticals is -45% over three years. In the latest year (FY 2019) revenue fell 56%. CAGR is the steady yearly rate that links the first and the last year.
No. Dux Ducis Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Dux Ducis Pharmaceuticals is U51101MH2014PTC254173. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dux Ducis Pharmaceuticals was incorporated on 12 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dux Ducis Pharmaceuticals by revenue are Ecm Engineers (India) Private Limited, Dr Herbmed Private Limited, N.N. Drugs Private Limited, Jas-Jai Tradecon Private Limited, D R T Pipes Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals).
Vaibhav Himatrao Pande was appointed as Additional Director on 15 Dec 2018. Yogesh Subhash Kanchalwar was appointed as Additional Director on 15 Dec 2018. Prashant Rupchand Pakhidde was appointed as Additional Director on 18 Sep 2017. Dux Ducis Pharmaceuticals has 7 board changes on record in total.
The registered office of Dux Ducis Pharmaceuticals is at Shop No. 3 Beach View Apt Palm Beach Road Sector 6 Nerul, Navi Mumbai, Maharashtra, India – 400706.